Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Discover how to utilize your skills to generate extra cash. Unlock new income opportunities today.
20,528 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
What could push the aave token could climb in the next decade? This guide breaks down the catalysts, risks, and pract...
Amazon is exploring a new growth lane: selling its Trainium AI chips to external customers. This article breaks down ...
Spot Bitcoin ETFs posted a seventh straight week of net outflows, with about $1.8 billion pulled in the week ending J...
Coastal thefts show a chilling pattern: suspects watching surfers hide keys, then using stolen info to raid cars and ...
Nike just 11-year low signals a pivotal moment for the brand and its investors. This article breaks down what's weigh...
Anthropic reports that the Trump administration has removed major usage restrictions on Claude Fable 5 and Mythos 5. ...
As AI moves from experiments to real workloads, the need for secure, low-latency data paths grows. This look explores...
JEPI investors missed 13.21% gains in a strong market as an options overlay muted upside and taxes eroded income. Thi...
Charleston remains a top retirement draw, but a $975,000 plan must account for coastal housing, insurance, and health...
Rivian priced a 75 million share secondary offering, sending its stock down around 14% and triggering a market-wide p...
AI infrastructure names rebounded on Wednesday, led by Terawulf and IREN as risk appetite returns to tech equities. A...